Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression.
Maeso-Díaz R, Du K, Pan C, Guy CD, Oh SH, Chen T, Wang L, Ko DC, Tang L, Dutta RK, Jun JH, Suzuki A, Abdelmalek MF, Wang XF, Diehl AM.
Maeso-Díaz R, et al. Among authors: wang xf, wang l.
Hepatology. 2023 Oct 1;78(4):1209-1222. doi: 10.1097/HEP.0000000000000401. Epub 2023 Apr 11.
Hepatology. 2023.
PMID: 37036206